Minerva Neuroscience

About:

Minerva Neurosciences focuses on the development and commercialization of a portfolio of product candidates to treat CNS diseases.

Website: http://minervaneurosciences.com

Top Investors: Cormorant Asset Management, Perceptive Advisors, MetLife, Index Ventures, Dafna Capital Management

Description:

Minerva Neurosciences is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat central nervous system (CNS) diseases. Our goal is to transform the lives of patients with improved therapeutic options and a patient-centric focus. Leveraging extensive domain expertise, we have identified and acquired or in-licensed a portfolio of development-stage proprietary compounds with innovative mechanisms of action.